SCHEMBL1980132

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL30939608	1.00	AR (0.50)	AROXTRHTTMMP13LMNA
	SCHEMBL18953079	0.89	AR (0.47)	AROXTR
	SCHEMBL13828612	0.82	AR (0.52)	AROXTRHTTMMP13LMNA
	SCHEMBL1772478	0.80	AR (0.55)	ARLMNATSHRMEN1TP53
	SCHEMBL12593838	0.79	AR (0.46)	ARHTTMMP13LMNATSHR
	SCHEMBL30939575	0.78	AR (0.47)	ARMMP13LMNATSHRMEN1
	SCHEMBL1983940	0.78	AR (0.47)	ARMMP13LMNATSHRMEN1
	SCHEMBL30939511	0.78	OXTR (0.46)	AROXTRMMP13LMNATSHR
	SCHEMBL1980479	0.78	OXTR (0.46)	AROXTRMMP13LMNATSHR
	SCHEMBL12595092	0.78	AR (0.43)	AROXTRMMP13LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.